Log In Sign up
The largest database of trusted experimental protocols

Spss 14.0k software

Manufactured by IBM
Visit Supplier
Sourced in United States

SPSS 14.0K is a statistical software package developed by IBM. It provides advanced analytical capabilities for data management, statistical analysis, and reporting. The software offers a wide range of features and tools to assist researchers, analysts, and decision-makers in exploring, visualizing, and interpreting data.

Automatically generated - may contain errors

Lab products found in correlation

Close spelling variants of this product

SPSS 14.0 (62 citations) SPSS software 14.0 (16 citations) SPSSTM (8 citations) SPSS 14.0K (4 citations) SPSS softwares (4 citations) SPSS for Windows software package, version 14.0K (2 citations)

2 protocols using spss 14.0k software

1

Comparative Statistical Analysis of Biological Replicates

Check if the same lab product or an alternative is used in the 5 most similar protocols
All statistical analyses were carried out using the SPSS 14.0K software (SPSS Inc., Chicago, IL, USA). Unless indicated otherwise, the data sets consist of at least three biological replicates, and the data are expressed as the mean ± SD. Statistical significance was determined by a two-sample t-test, and null hypotheses of no difference were rejected if p-values were <0.05.
MOON D.G., LEE S.E., OH M.M., LEE S.C., JEONG S.J., HONG S.K., YOON C.Y., BYUN S.S., PARK H.S, & CHEON J. (2014). NVP-BEZ235, a dual PI3K/mTOR inhibitor synergistically potentiates the antitumor effects of cisplatin in bladder cancer cells. International Journal of Oncology, 45(3), 1027-1035.
+ Open protocol
+ Expand
2

Biological Replicates Statistical Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
The data sets consisted of at least three biological replicates, and all statistical analyses were performed using SPSS 14.0 K software (SPSS Inc., Chicago, IL, USA). The data are expressed as a mean±SD. Statistical significance was determined by a two-sample t-test, and differences were considered significant at p<0.05.
Kim H.J., Gong M.K., Yoon C.Y., Kang J., Yun M., Cho N.H., Rha S.Y, & Choi Y.D. (2020). Synergistic Antitumor Effects of Combined Treatment with HSP90 Inhibitor and PI3K/mTOR Dual Inhibitor in Cisplatin-Resistant Human Bladder Cancer Cells. Yonsei Medical Journal, 61(7), 587-596.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!